A. Marchal

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with critical COVID-19

Y. Zhang, A. Bolze, Lennart Hammarstrom, 2022, medRxiv.

A First-in-Human Study of YTB323, a Novel, Autologous CD19-Directed CAR-T Cell Therapy Manufactured Using the Novel T-Charge TM platform, for the Treatment of Patients (Pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

J. Briones, I. Flinn, U. Jaeger, 2021, Blood.

SKA science data challenge 2: analysis and results

M. C. Toribio, J. Kneib, M. Jirstrand, 2023, Monthly Notices of the Royal Astronomical Society.

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

J. Briones, I. Flinn, D. Blaise, 2023, Cancer discovery.